SEND A MESSAGE
Please fill in this form and we’ll get back to you as soon as we can.
NeuroCores Address
201 Washington Street, Suite 2600, Boston, MA. 02108
Contact
info@neurocores.com
News & Updates
KIT-20, a promising therapy for Leigh Syndrome, has been granted Orphan Drug and Rare Pediatric Drug Designations by the US FDA. This marks another milestone achievement for NeuroCores in our journey to develop treatments for rare pediatric neurological disorders.
There are now 2 pipeline assets – KIT-13 for Rett Syndrome and KIT-20 for Leigh Syndrome – that have been granted both Orphan Drug and Rare Pediatric Drug Designations by the US FDA.
Follow us on